Topiramate in clinical practice: Long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center

Epilepsy and Behavior

Volumn 5, Issue 3, 2004, Pages 380-387

  Bootsma, H P R ^a   Coolen, F ^a   Aldenkamp, A P ^a,b,c   Arends, J ^a   Diepman, L ^a   Hulsman, J ^a   Lambrechts, D ^a   Leenen, L ^a   Majoie, M ^a   Schellekens, A ^a   de Krom, M ^b  

^a EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Antiepileptics; Cognitive function; Long term retention; Side effects of antiepileptic drugs; Topiramate

Indexed keywords

ACETAZOLAMIDE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ANTICONVULSIVE AGENT; DRUG DERIVATIVE; FRUCTOSE;

ADOLESCENT; ADULT; AGED; ANOREXIA; ARTICLE; ATAXIA; BEHAVIOR DISORDER; BODY WEIGHT DISORDER; BONE DISEASE; CARDIOVASCULAR DISEASE; CHILD; CLINICAL PRACTICE; CONTROLLED STUDY; DIPLOPIA; DIZZINESS; DOSE RESPONSE; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; DRUG WITHDRAWAL; DYSPHASIA; ENDOCRINE DISEASE; EXPERIENCE; EYE DISEASE; FEMALE; FOCAL EPILEPSY; GASTROINTESTINAL DISEASE; HEADACHE; HEALTH CARE FACILITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEDICAL DECISION MAKING; MEMORY DISORDER; MENTAL DEFICIENCY; MOOD DISORDER; MUSCLE DISEASE; NEPHROLITHIASIS; NETHERLANDS; NEUROLOGIC DISEASE; PARESTHESIA; PATIENT REFERRAL; PROGNOSIS; PSYCHOSIS; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; SKIN DISEASE; SLEEP DISORDER; SURVIVAL; TITRIMETRY; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE; WEIGHT GAIN; WEIGHT REDUCTION; CLASSIFICATION; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ADMINISTRATION; EPILEPSY; INFANT; LONGITUDINAL STUDY; MIDDLE AGED; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TIME;

ADOLESCENT; ADULT; AGED; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 3042666044     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2004.03.002     Document Type: Article

References (12)

1. Stefan H. Krämer G. Mamoli B. Challenge epilepsy: new antiepileptic drugs 1998 Blackwell Science Berlin
2. White H.S. Clinical significance of animal seizure models and mechanism of action studies of potential antiepileptic drugs Epilepsia 38 Suppl. 1 1997 S9-S17
3. Faught E. Wilder B.J. Ramsay R.E. et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, 600 mg dosages Neurology 46 1996 1684-1690
4. Rosenfeld W.E. Topiramate: a review of preclinical pharmacokinetic and clinical data Clin. Ther. 19 1997 1294-1308
5. Lhatoo S.D. Wong I.C.K. Sander J.W.A.S. Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy Epilepsia 41 2000 338-341
6. Kellet M.W. Smith D.F. Stockton P.A. Chadwick D.W. Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic J. Neurol. Neurosurg. Psychiatr. 66 1999 759-763
7. Wong I.C.K. New antiepileptic drugs: study suggests that a quarter of patients will still be taken the new drugs after six years Br. Med. J. 314 1997 603-604
8. Tatum W.O. French J.A. Faught E. et al. Postmarketing experience with topiramate and cognition Epilepsia 42 2001 1134-1140
9. Aldenkamp A.P. Cognitive effects of topiramate, gabapentin and lamotrigine in healthy young adults Neurology 54 2000 270-272
10. Kaplan E.L. Non-parametric estimation from incomplete observations Am. Stat. Assoc. J. 53 1958 457-481
11. Vermeulen J. Aldenkamp A.P. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research Epilepsy Res. 22 1995 65-95
12. Aldenkamp A.P. Baker G. Mulder O.G. et al. A multicentre randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures Epilepsia 41 2000 1167-1178